Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
imetelstat
Biotech
Geron secures 12-2 AdComm vote in favor of blood cancer drug
The biotech won over an FDA advisory committee and secured a 12 to 2 vote in its favor—triggering a surge in its share price.
Nick Paul Taylor
Mar 15, 2024 5:00am
FDA questions benefit-risk profile of Geron's imetelstat
Mar 12, 2024 12:20pm
J&J builds on Geron partnership despite ongoing setbacks
Sep 20, 2016 7:42am